Molecular imaging methods for diagnosis and evaluation of ocular and systemic diseases
OwnerAli Hafezi-Moghadaminventor
Life of this patent
Estimating the term…
Loading patent…
OwnerAli Hafezi-Moghadaminventor
Estimating the term…
This invention relates generally to minimally-invasive, in vivo methods of detecting one or more ligands on an intraluminal surface of a blood vessel using microparticles coated with one or more ligand binding partners. More particularly, in certain embodiments, the invention relates to minimally-invasive, in vivo methods of detecting endothelial and leukocyte antigens that are predictive of diabetic retinopathy (DR) and/or other conditions using protein-conjugated microparticles detectable by a non-invasive detection system, for example, a scanning laser opthalmoscope. In other embodiments, the invention relates to targeted delivery of drugs or other substances to specific regions of an intraluminal surface of a blood vessel using drug-containing microparticles coated with one or more ligand binding partners.
A minimally invasive method for the in vivo detection of one or more ligands on an intraluminal surface of a blood vessel, the method comprising:
(canceled)
-15. (canceled)
-20. (canceled)
(canceled)
-29. (canceled)
-35. (canceled)
-42. (canceled)
-48. (canceled)
-58. (canceled)
(canceled)
(canceled)
(canceled)
-90. (canceled)
A method for the delivery of one or more agents to a targeted intraluminal surface of a blood vessel, the method comprising:
-98. (canceled)
(canceled)
A method for the delivery of one or more agents to a targeted intraluminal surface of a blood vessel, the method comprising administering to a subject microparticles carrying one or more agents, wherein the microparticles have an average diameter less than a diameter of a blood vessel of the subject in which the microparticles travel, and wherein the microparticles have a surface to which one or more binding substances are conjugated, wherein the one or more binding substances bind to one or more ligands on a targeted intraluminal surface of the blood vessel, thereby immobilizing the microparticles on the targeted intraluminal surface.
Dependencies are inferred from the claim text.